Adicet Bio (GB:0HX7)
LSE:0HX7
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 10, 2025 | xxxxxxxxxxxxx | $5000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $5262500 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $7984256 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,420,781 | Insider | 77.47% | 56,323,728 | |
| 3,602,981 | Institution | 37.62% | 27,346,626 | |
| 1,236,453 | Institution | 12.91% | 9,384,678 | |
| 948,249 | Institution | 9.90% | 7,197,210 | |
| 625,000 | Institution | 6.53% | 4,743,750 | |
| 288,364 | Institution | 3.01% | 2,188,683 | |
| 225,511 | Institution | 2.35% | 1,711,628 | |
| 147,300 | Institution | 1.54% | 1,118,007 | |
| 108,566 | Insider | 1.13% | 824,016 | |
| 80,194 | Institution | 0.84% | 608,672 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,602,981 | Institution | 37.62% | 27,346,626 | |
| 225,511 | Institution | 2.35% | 1,711,628 | |
| 147,300 | Institution | 1.54% | 1,118,007 | |
| 80,194 | Institution | 0.84% | 608,672 | |
| 56,350 | Institution | 0.59% | 427,697 | |
| 19,898 | Institution | 0.21% | 151,026 | |
| 10,211 | Institution | 0.11% | 77,501 | |
| 6,046 | Institution | 0.06% | 45,889 | |
| 4,800 | Institution | 0.05% | 36,432 | |
| 4,165 | Institution | 0.04% | 31,612 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Adicet Bio (GB:0HX7)?
Currently, no data Available
What percentage of Adicet Bio (GB:0HX7) stock is held by institutional investors?
Currently, no data Available
What percentage of Adicet Bio (GB:0HX7) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adicet Bio (GB:0HX7)?
Orbimed Advisors Llc owns the most shares of Adicet Bio (GB:0HX7).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.